PHUSIS THERAPEUTICS INC has a total of 11 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are TEMPEST THERAPEUTICS INC, MIRATI THERAPEUTICS INC and UNIV OF PUERTO RICO.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Kirkpatrick D Lynn | 9 |
#2 | Indarte Martin | 9 |
#3 | Ihle Nathan T | 6 |
#4 | Johnson Jennifer L H | 2 |
#5 | Kirkpatrick Lynn D | 2 |
Publication | Filing date | Title |
---|---|---|
US2016304533A1 | Compounds, compositions and methods for inhibiting CNKSR1 | |
AU2013358876A1 | Methods and compositions for inhibiting CNKSR1 | |
EP2477625A2 | Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same |